Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00002984What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the EsophagusWho this might be right forEsophageal Cancer UNC Lineberger Comprehensive Cancer Center 26
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Early research (Phase 1)Study completedNCT00003427What this trial is testingOxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerWho this might be right forAnal CancerColorectal CancerEsophageal Cancer+7 more Memorial Sloan Kettering Cancer Center 36
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Testing effectiveness (Phase 2)Study completedNCT00004233What this trial is testingS9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or StomachWho this might be right forEsophageal CancerGastric Cancer SWOG Cancer Research Network 65
Testing effectiveness (Phase 2)Study completedNCT01231399What this trial is testingEverolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+6 more City of Hope Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT02830594What this trial is testingPembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction CancerWho this might be right forGastric AdenocarcinomaGastric Squamous Cell CarcinomaGastroesophageal Junction Adenocarcinoma+3 more City of Hope Medical Center 14
Testing effectiveness (Phase 2)Study completedNCT00258323What this trial is testingRadiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer Case Comprehensive Cancer Center 80
Not applicableStudy completedNCT00628368What this trial is testingBiological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerWho this might be right forColorectal CancerEsophageal Cancer Institut du Cancer de Montpellier - Val d'Aurelle 160
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Testing effectiveness (Phase 2)Active Not RecruitingNCT06251973What this trial is testingAgenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerWho this might be right forMetastatic Esophageal CarcinomaAdvanced Unresectable Gastric AdenocarcinomaMetastatic Gastric Cancer+10 more Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT03161522What this trial is testingChemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerWho this might be right forGastric AdenocarcinomaOligometastasisStage IV Esophageal Adenocarcinoma AJCC v7+2 more M.D. Anderson Cancer Center 100
Early research (Phase 1)Ended earlyNCT02757391What this trial is testingCD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsWho this might be right forColorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT01631552What this trial is testingStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerWho this might be right forGastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more Gilead Sciences 515
Very early researchStudy completedNCT03395847What this trial is testingPembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaWho this might be right forAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8+22 more M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00238407What this trial is testingDocetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By SurgeryWho this might be right forEsophageal Cancer Swiss Cancer Institute 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT01142388What this trial is testingPaclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerWho this might be right forMetastatic Esophageal AdenocarcinomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+5 more National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Study completedNCT00030862What this trial is testingCombination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusWho this might be right forEsophageal Cancer Memorial Sloan Kettering Cancer Center